Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference13 articles.
1. Immunotherapy in lung cancer;Massarelli;Transl Lung Cancer Res,2014
2. Biomarker definitions and their applications;Califf;Exp Biol Med,2018
3. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016
4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok,2019
5. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018